Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800019773Phase 4Recruiting
Phase 4, open-label trial of sevoflurane and propofol in Cardiac valve disease (VHD) (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: 8-OHdG. Started Dec 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800019773.